Bisrat Woldemichael, PhD
About Bisrat Woldemichael, PhD
Bisrat Woldemichael, PhD, is the Principal Marketing Strategy & Analysis Manager for Neuromodulation at Boston Scientific, with a diverse background in neuroscience, business development, and consulting.
Principal Marketing Strategy & Analysis Manager at Boston Scientific
Bisrat Woldemichael, PhD, holds the position of Principal Marketing Strategy & Analysis Manager for the Neuromodulation division at Boston Scientific. He has been with the company since 2021 and is based in the New York City Metropolitan Area. In this role, he is responsible for driving the marketing strategies and analyzing market data to support the company's neuromodulation products and services.
Associate Consultant Experience at McKinsey & Company
From 2019 to 2021, Bisrat Woldemichael worked as an Associate Consultant at McKinsey & Company in New York, New York. During his tenure, he engaged in consulting projects that required strategic analysis and advising clients on business development and operational improvements.
Business Development Role at Mount Sinai Innovation Partners
Bisrat Woldemichael served as part of the Business Development team at Mount Sinai Innovation Partners from 2017 to 2018. His responsibilities included fostering partnerships and driving innovation initiatives within the Greater New York City Area.
Extensive Background in Neuroscience and Public Health
Bisrat Woldemichael boasts a comprehensive educational background, which includes a Doctor of Philosophy (Ph.D.) in Neuroscience from ETH Zürich (2010-2014), a Master of Science (MSc) in Neurobiology from University of Eastern Finland (2007-2009), a Master of Science (MSc) in Medical Physiology from Addis Ababa University (2005-2007), and a Bachelor of Science (B.Sc.) in Public Health from Haramaya University (2000-2004).
Research and Postdoctoral Fellowships
Dr. Woldemichael's research career includes significant roles such as a Postdoctoral Fellow at the Brain Research Institute, University of Zurich / ETH Zurich from 2014 to 2016, and at Icahn School of Medicine at Mount Sinai from 2016 to 2018. He also served as a Researcher at the Brain Research Institute, University of Zurich / ETH Zurich from 2010 to 2014. His work focused on advancing neuroscience research and contributing to academic knowledge in the field.